Gilbert Nathan Joins Accelerate Diagnostics Board with Zero Initial Stake
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Gilbert E. Nathan has filed a Form 3 (Initial Statement of Beneficial Ownership) following his appointment as Director at Accelerate Diagnostics (AXDX). The filing, dated June 28, 2025, discloses Nathan's beneficial ownership position as of April 10, 2025.
Key details from the filing:
- Nathan currently holds no securities (derivative or non-derivative) beneficially owned in the company
- The filing confirms his position as Director but indicates no other roles such as Officer or 10% Owner
- This is an individual filing, not a joint/group submission
- Business address is listed as 3950 S. Country Club Road, Suite 470, Tucson, AZ 85714
This Form 3 filing is a standard regulatory requirement for new directors under Section 16(a) of the Securities Exchange Act of 1934, establishing a baseline for future ownership reporting.
Positive
- None.
Negative
- None.
FAQ
Who is the new director appointed to AXDX's board in April 2025?
Gilbert E. Nathan was appointed as a Director of Accelerate Diagnostics (AXDX) effective April 10, 2025, as indicated in the Form 3 filing.
What is Gilbert Nathan's role at AXDX as of April 2025?
Gilbert Nathan serves as a Director at Accelerate Diagnostics (AXDX). The Form 3 indicates he is not an officer or 10% owner, but solely holds the position of Director.
When did Gilbert Nathan file his initial Form 3 for AXDX?
Gilbert Nathan filed his Form 3 (Initial Statement of Beneficial Ownership) on June 25, 2025, as evidenced by the signature date on the filing, reporting his beneficial ownership following his appointment as Director on April 10, 2025.